{
  "id": "1cd8fe04652863eb",
  "title": "Zai Lab Augtyro receives NMPA approval for solid tumours in China",
  "description": "20260107T130000Z",
  "content": "",
  "source": "pharmaceutical-business-review.com",
  "source_url": "https://www.pharmaceutical-business-review.com/news/zai-labs-augtyro-nmpa-approval/",
  "published_at": "20260107T130000Z",
  "fetched_at": "2026-01-08T00:23:56.998868+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "ai",
    "china"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.pharmaceutical-business-review.com/news/zai-labs-augtyro-nmpa-approval/",
    "url_mobile": "https://www.pharmaceutical-business-review.com/news/zai-labs-augtyro-nmpa-approval/amp/",
    "title": "Zai Lab Augtyro receives NMPA approval for solid tumours in China",
    "seendate": "20260107T130000Z",
    "socialimage": "https://www.pharmaceutical-business-review.com/wp-content/uploads/2026/01/PT-07-01-2025-shutterstock_2410513321.jpg",
    "domain": "pharmaceutical-business-review.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}